> It's research. Not marketing. Costs so much to__research__these drugs
> doncha know? That's why they don't have the money to monitor side
> effect
> Research costs so much.
>
[quoted text clipped - 15 lines]
> Pfizer rep confirmed the review, but declined to identify the
> participants, which sources expect to be briefed this week.
> > It's research. Not marketing. Costs so much to__research__these drugs
> > doncha know? That's why they don't have the money to monitor side
> > effect
>
> actually it does...cost so much to research I mean..
No it doesn't.
> average to get a drug to market is about 800 MILLION(getting to market
> obviously INCLUDES monitoring side effects)
Would you be able to give me a cite for that? Both the cost, and that
the figure includes monitoring side effects.
> soo....
>
> the article you post says 60 - 80 to "pitch"...ie market...
No it didn't say that was the cost to get Lipitor to market.
The article I posted said $60-$80 Mil for *one* new marketing campaign.
Lipitor is already on the market, and there have been many campaigns.
> hmmmm....so marketing costs 10% of development costs......
No it doesn't.
> what's your problem
> now look up how much say...Mercedes spends to develop a new model car,,,then
> how much to pitch it...just curious
I'm always at a loss to know what to do when you embarrass yourself as
you have just done Hawki. Should I try to hold your head above water
until the rescue boat arrives...or should I just swim away and let you
drown?
Approximately 35% of (a drugs's) revenue goes to marketing and
administration (versus about 18-19% for R&D) but that amount is almost
never broken down. The source is Marcia Angell's book "The Truth About
the Drug Companies". This excerpt discusses R & D and marketing but you
may have to read the book for the analysis and charts.
http://www.nybooks.com/articles/17244
> > Research costs so much.
> >
[quoted text clipped - 15 lines]
> > Pfizer rep confirmed the review, but declined to identify the
> > participants, which sources expect to be briefed this week.
Robert - 29 Jun 2005 06:56 GMT
So sue like everyone else or have the government do it and then you can't
sue them.
Have the government develop drugs and like vaccines they can protect
themselves against lawsuits.
Hawki63@sbcglobal.net - 29 Jun 2005 07:45 GMT
>> > It's research. Not marketing. Costs so much to__research__these drugs
>> > doncha know? That's why they don't have the money to monitor side
[quoted text clipped - 3 lines]
>
> No it doesn't.
oh??
>> average to get a drug to market is about 800 MILLION(getting to market
>> obviously INCLUDES monitoring side effects)
>
> Would you be able to give me a cite for that? Both the cost, and that
> the figure includes monitoring side effects.
be happy to...perhaps you don't have google...btw..."figure of r and d costs
including monitoring of side effects in development stages..ie clinical
trials...average time to get a new drug to market can be up to 10-12
years...
cites:
www.cptech.org/ip/health/econ/frank/2003.pdf
snip "DiMasi et al (2003) have estimated the average costs of bringing a new
drug to market to be US$ 403 million in 2000 dollars. Accounting for the
time between investment and marketing raises the cost to US$802 million...."
"not to mention that about 78% of new products never make it to
market"...but still incur huge r and d costs..
btw..be prepared to learn about "out of pocket" and "capitalized costs"....
""we have always provided both out of pocket and capitalized cost estimates.
The out of pocket costs are cash outlays incurred ober a lengthy development
period..as much as a 12 year timeline from discovery to regulatory
approval..Capitalized cost is the total cost that really must be
considered..It accounts for what I would call the "time cost" associated
with an investment..These costs estimates also include the testing of drugs
that fail in development..The total out of pocket cost is about $400 million
per approved drug,,and the total capitalized cost is about $800 million per
appropred drug"
(paraphrased from : www.manhattan-institute.org/html/mics 8.htm)
>> soo....
>>
[quoted text clipped - 18 lines]
> until the rescue boat arrives...or should I just swim away and let you
> drown?
merely pointing out that EVERY industry has considerable marketing costs....
hold MY head above water?? lol...
> Approximately 35% of (a drugs's) revenue goes to marketing and
> administration (versus about 18-19% for R&D) but that amount is almost
[quoted text clipped - 23 lines]
>> > Pfizer rep confirmed the review, but declined to identify the
>> > participants, which sources expect to be briefed this week.
zee - 29 Jun 2005 15:31 GMT
> >> > It's research. Not marketing. Costs so much to__research__these drugs
> >> > doncha know? That's why they don't have the money to monitor side
[quoted text clipped - 94 lines]
> >> > Pfizer rep confirmed the review, but declined to identify the
> >> > participants, which sources expect to be briefed this week.
You completely miss the point Hawki. I have no intention of holding you
by the hand and pointing out where you have gone wrong. It's your
responsibility.
You continue to make it abundantly clear why having a medical license
is not enough reason alone to pay any attention to what the holder
says.
Zee
Hawki63@sbcglobal.net - 29 Jun 2005 19:13 GMT
>> >> > It's research. Not marketing. Costs so much to__research__these
>> >> > drugs
[quoted text clipped - 115 lines]
>
> Zee
nor does claiming that one is a "journalist" means the holder can interpret
business articles..
btw....Marcia Angell....yeah that's a truly unbiased source..and only one at
that..
interesting that you did not comment on my several cites you requested that
documents the $800 million r and d costs!!
that was your request to me...
zee - 30 Jun 2005 05:11 GMT
> >> >> > It's research. Not marketing. Costs so much to__research__these
> >> >> > drugs
[quoted text clipped - 126 lines]
>
> that was your request to me...
Now just go back and read the words over slowly Hawki.
Until it dawns on you ....
Zee